Inventor

ZHANG YUE-MEI

US50 patents

⚠️ This page may combine multiple inventors who share the name “ZHANG YUE-MEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZHANG YUE-MEI

JANSSEN PHARMACEUTICA NV

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Immunoglobulins and uses thereof

Pyrimidine compounds as delta opioid receptor modulators

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Immunoglobulins and uses thereof

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoglobulins and uses thereof

Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors

Quinoline derivatives useful as CB-1 inverse agonists

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Heterocyclic derived metalloprotease inhibitors

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

Benzimidazole derivatives useful as CB-1 inverse agonists

Quinoline derivatives useful as CB-1 inverse agonists

Phenoxy-substituted pyrimidines as opioid receptor modulators

Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof

Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists

Cinnoline derivatives useful as CB-1 receptor inverse agonists

Quinazoline derivatives useful as CB-1 inverse agonists

BIAN HAIYAN

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

Azetidinyl diamides as monoacylglycerol lipase inhibitors

CONNOLLY PETER J

Pyrazines as delta opioid receptor modulators

Pyrazines as delta opioid receptor modulators

COATS STEVEN J

Pyrimidine compounds as delta opioid receptor modulators

Phenoxy-substituted pyrimidines as opioid receptor modulators

JANSSEN SCIENCES IRELAND UNLIMITED CO

Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof

PARABILIS MEDICINES INC

Collections of peptides, peptide agents, and methods of use thereof

ZHANG YUE-MEI

Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors